![](/img/cover-not-exists.png)
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
M. H. Imam, E. Sinakos, A. A. Gossard, K. V. Kowdley, V. A. C. Luketic, M. Edwyn Harrison, T. McCashland, A. S. Befeler, D. Harnois, R. Jorgensen, J. Petz, J. Keach, A. C. DeCook, F. Enders, K. D. LinVolume:
34
Year:
2011
Language:
english
Pages:
8
DOI:
10.1111/j.1365-2036.2011.04863.x
File:
PDF, 226 KB
english, 2011